Connor K Sisk, Victoria Jiminez, Michael Anderson, Hamza Malick, Umer Nadir, George M Jeha, Stanislav N Tolkachjov
{"title":"Staging, workup, neoadjuvant/adjuvant therapy, and treatment options for cutaneous squamous cell carcinoma.","authors":"Connor K Sisk, Victoria Jiminez, Michael Anderson, Hamza Malick, Umer Nadir, George M Jeha, Stanislav N Tolkachjov","doi":"10.23736/S2784-8671.26.08667-6","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08667-6","url":null,"abstract":"<p><p>Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer worldwide and represents a growing source of morbidity and mortality. Incidence continues to rise globally, driven by an aging population, cumulative ultraviolet exposure, and increasing prevalence of high-risk patient populations. While most cSCCs follow an indolent course, a clinically meaningful subset can demonstrate aggressive behavior, highlighting the need for accurate risk stratification and individualized management strategies. This narrative review synthesizes contemporary evidence regarding the clinical presentation, tumor biology, diagnostic evaluation, staging systems, and treatment paradigms for cSCC with emphasis on emerging prognostic tools shaping future care. We summarize key clinical and histopathologic features associated with adverse outcomes, including depth of invasion, differentiation, and perineural involvement, and review current imaging and nodal assessment strategies. Staging frameworks, including American Joint Committee on Cancer (AJCC), Brigham and Women's Hospital (BWH), and evolving stages of the National Comprehensive Cancer Network (NCCN) systems, are discussed alongside newer models such as risk-integrated squamous cell carcinoma staging, which aim to improve outcome discrimination. Treatment approaches encompassing surgery, radiation therapy, and systemic immunotherapy are reviewed, with particular attention to risk-adapted use of Mohs micrographic surgery, adjuvant radiation therapy (ART), and neoadjuvant or definitive programmed cell death protein-1 (PD-1) blockade for advanced disease. Finally, we examine emerging molecular prognostic assays, including gene expression profiling (GEP), that offer biologic insight beyond traditional clinicopathologic factors and may refine decisions regarding surveillance and treatment escalation. As the burden of cSCC continues to expand, integrated frameworks incorporating clinical, histopathologic, and molecular data will be essential for optimizing outcomes while minimizing patient and system-level burdens, particularly for identifying tumors requiring treatment escalation.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luisa Boeti, Gennaro M Falco, Nicoletta Bernardini, Ersilia Tolino, Niccolò Gori, Clara DE Simone, Ketty Peris, Giacomo Caldarola
{"title":"Psoriasis occurrence in patients with atopic dermatitis treated with dupilumab and tralokinumab.","authors":"Luisa Boeti, Gennaro M Falco, Nicoletta Bernardini, Ersilia Tolino, Niccolò Gori, Clara DE Simone, Ketty Peris, Giacomo Caldarola","doi":"10.23736/S2784-8671.26.08612-3","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08612-3","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of paradoxical pustular psoriasis and alopecia of the scalp caused by infliximab in a patient affected by Crohn disease.","authors":"Chiara Bocchi, Lucrezia Pacetti, Simone Cavaliere, Alessandro Borghi, Natale Schettini","doi":"10.23736/S2784-8671.26.08265-4","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08265-4","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Davide Bertolla, Federico Tartari, Alfonso Motolese, Anna R Lombardi, Alessandro Borghi, Andrea Conti
{"title":"A staged, function-preserving approach for a massive lentigo maligna crossing the lip mucocutaneous junction.","authors":"Davide Bertolla, Federico Tartari, Alfonso Motolese, Anna R Lombardi, Alessandro Borghi, Andrea Conti","doi":"10.23736/S2784-8671.26.08633-0","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08633-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Rapid clinical improvement of erythrodermic-onset psoriasis with bimekizumab.","authors":"Andrea Coretti, Claudia Lasagni, Caterina Longo","doi":"10.23736/S2784-8671.26.08681-0","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08681-0","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana M Giménez-Arnau, Francesca Barei, Andaç Salman
{"title":"The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach.","authors":"Ana M Giménez-Arnau, Francesca Barei, Andaç Salman","doi":"10.23736/S2784-8671.26.08590-7","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08590-7","url":null,"abstract":"<p><p>Chronic spontaneous urticaria (CSU) is a heterogeneous mast cell-driven disease associated with a substantial burden on patients' quality of life. Although most patients achieve disease control with guideline-recommended therapies, a relevant proportion remains refractory, highlighting important unmet needs. This narrative review summarizes current, emerging, and investigational treatments for CSU, discussing them with a pathogenesis-driven and endotype-oriented approach. Established therapies, including second-generation H1-antihistamines and omalizumab, are discussed alongside recently approved and upcoming agents such as dupilumab and Bruton's tyrosine kinase inhibitors, particularly remibrutinib. In addition, novel strategies targeting mast cell survival and activation (antireceptor tyrosine kinase therapies), intracellular signaling pathways (Janus Kinase and Tyrosine kinase 2inhibitors), immunoglobulin E-independent activation (Mas-related G protein-coupled receptor X2 antagonists), and next-generation anti-immunoglobulin E antibodies are reviewed. Beyond symptom control, the concepts of complete disease control, remission, relapse, and disease modification are examined. The evolving therapeutic landscape of CSU is expected to enable a more personalized management, with the potential to achieve sustained remission and, ultimately, disease modification in selected patients.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emanuele Scala, Valentina Dini, Chiara Fiorentini, Federico Garbarino, Agata Janowska, Andrea Marani, Davide Melandri, Andrea Michelerio, Paola Monari, Nicolò Mori, Alberico Motolese, Marco Romanelli, Linda Tognetti, Alessia Paganelli
{"title":"What's new in wound care: dermatological pearls from the 99th National Congress of the Italian Society of Medical, Surgical, Aesthetic Dermatology and Sexually Transmitted Diseases (SIDeMaST).","authors":"Emanuele Scala, Valentina Dini, Chiara Fiorentini, Federico Garbarino, Agata Janowska, Andrea Marani, Davide Melandri, Andrea Michelerio, Paola Monari, Nicolò Mori, Alberico Motolese, Marco Romanelli, Linda Tognetti, Alessia Paganelli","doi":"10.23736/S2784-8671.26.08749-9","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08749-9","url":null,"abstract":"","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pre-exposure prophylaxis for HIV: a review for dermatovenereologists.","authors":"Luigi Pisano, Martina Turco, Nicola Pimpinelli","doi":"10.23736/S2784-8671.26.08434-3","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08434-3","url":null,"abstract":"<p><p>Human immunodeficiency virus (HIV) infection remains a significant public health issue, with 112,883 new diagnoses reported in Europe in 2023. The rise is particularly notable in Eastern Europe, where new cases increased by 20% between 2010 and 2023. Late diagnosis is a major barrier to HIV control, with nearly 50% of new infections in Europe - and up to 60% in Italy - detected at an advanced stage. Dermatovenereologists are key in early detection, as over 90% of people living with HIV show at least one HIV-related dermatologic condition before diagnosis. Thus, dermatovenereology services are well-positioned to promote routine HIV testing and prevention. Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method but is unevenly implemented across Europe. In Italy, PrEP is mostly prescribed by infectious disease specialists, except at a pioneering sexually transmitted infections (STI) center in Florence where dermatovenereologists can also prescribe it. Expanding this prescribing authority nationwide could improve access and prevention efforts among underserved populations. Integrating PrEP into dermatovenereology would enhance the continuum of care by linking STI screening, treatment, counseling, and HIV prevention, supporting UNAIDS' goal of ending AIDS by 2030. This narrative review summarizes key studies leading to PrEP approval, outlines approved administration methods for at-risk groups, discusses potential side effects, and highlights emerging therapeutic options under regulatory review (such as long-acting PrEP). It aims to equip dermatovenereologists with all the necessary tools to prescribe and manage PrEP effectively during follow-up.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"MicroRNA expression in vulvar lichen sclerosus keratinocytes and fibroblasts: further evidence and possible pathogenetic implications from an observational study.","authors":"Alessandro Borghi, Fernanda Martini, Lucilla D'Abundo, Cristian Bassi, Lucia Oton Gonzalez, Lucrezia Pacetti, Massimo Negrini, Monica Corazza","doi":"10.23736/S2784-8671.26.08591-9","DOIUrl":"https://doi.org/10.23736/S2784-8671.26.08591-9","url":null,"abstract":"<p><strong>Background: </strong>It seems established that genetic and epigenetic determinants drive the multifactorial pathogenic processes in vulvar lichen sclerosus (VLS). Aberrant expression of microRNAs (miRNAs) has been observed in a few studies suggesting their potential involvement. Our aim was to assess the expression of miRNAs both in VLS and in healthy keratinocytes and fibroblasts cultured separately.</p><p><strong>Methods: </strong>In this observational study, five VLS and five healthy skin tissue specimens were used to derive independent keratinocyte and fibroblast cultures. Total RNA, including miRNA, was isolated from cells, quantified and used to prepare a miRNA library. The quality and quantity of miRNA libraries were analyzed and sequenced. Differentially expressed miRNAs have been identified using DESeq2 bioconductor package.</p><p><strong>Results: </strong>The differential analysis led to the identification of 171 and 111 microRNAs with an expression difference of at least 1.5-fold between VLS and healthy samples, in keratinocytes and fibroblasts, respectively. More than 80% of the 111 microRNAs identified as differentially expressed in fibroblasts were also found to be differentially expressed in keratinocytes. Several dysregulated miRNAs are involved in inflammation and fibrotic processes, namely miR-10a-5p and 3p, miR-143-3p and 5p, miR-181a-5p and 3p, miR-181b-5p and 3p, miR-21-3p, miR-146b-5p and miR-29c.</p><p><strong>Conclusions: </strong>Our results showed a clear separation of VLS keratinocytes and fibroblasts from healthy cells in terms of miRNA expression. It is noteworthy that the most dysregulated miRNAs are implicated in inflammatory and fibrotic pathways. It is conceivable that miRNA expression is functional in regulating pathogenetic mechanisms of LS.</p>","PeriodicalId":14526,"journal":{"name":"Italian Journal of Dermatology and Venereology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149127430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}